Review: IFN-α/β Receptor Interactions to Biologic Outcomes: Understanding the Circuitry
暂无分享,去创建一个
[1] L. Cantley,et al. Phosphatidylinositol 3-Kinase Confers Resistance to Encephalomyocarditis and Herpes Simplex Virus-Induced Cell Death Through the Activation of Distinct Downstream Effectors1 , 2001, The Journal of Immunology.
[2] M. J. Cody,et al. TLR4, but not TLR2, mediates IFN-β–induced STAT1α/β-dependent gene expression in macrophages , 2002, Nature Immunology.
[3] G. Lutfalla,et al. Genetic transfer of a functional human interferon α receptor into mouse cells: Cloning and expression of its c-DNA , 1990, Cell.
[4] L. Platanias,et al. The Rac1/p38 mitogen-activated protein kinase pathway is required for interferon alpha-dependent transcriptional activation but not serine phosphorylation of Stat proteins. , 2000, The Journal of biological chemistry.
[5] S. Feller. Crk family adaptors–signalling complex formation and biological roles , 2001, Oncogene.
[6] N. Sonenberg,et al. The Murine Double-Stranded RNA-Dependent Protein Kinase PKR Is Required for Resistance to Vesicular Stomatitis Virus , 2000, Journal of Virology.
[7] M. Katze,et al. Functional expression and RNA binding analysis of the interferon-induced, double-stranded RNA-activated, 68,000-Mr protein kinase in a cell-free system , 1991, Molecular and cellular biology.
[8] J. Darnell. STATs and gene regulation. , 1997, Science.
[9] M. Grace,et al. Interferon‐α as an immunotherapeutic protein , 2002, Journal of Leukocyte Biology.
[10] G. Stark,et al. Mutant U5A cells are complemented by an interferon‐alpha beta receptor subunit generated by alternative processing of a new member of a cytokine receptor gene cluster. , 1995, The EMBO journal.
[11] G. Kochs,et al. Inhibition of bunyaviruses, phleboviruses, and hantaviruses by human MxA protein , 1996, Journal of virology.
[12] R. Flavell,et al. Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3 , 2001, Nature.
[13] L. Platanias,et al. Tyrosine phosphorylation of the alpha and beta subunits of the type I interferon receptor. Interferon-beta selectively induces tyrosine phosphorylation of an alpha subunit-associated protein. , 1994, The Journal of biological chemistry.
[14] M. Cooper,et al. Impairment of T and B Cell Development by Treatment with a Type I Interferon , 1998, The Journal of experimental medicine.
[15] T. Mak,et al. Activation of the dsRNA‐dependent protein kinase, PKR, induces apoptosis through FADD‐mediated death signaling , 1998, The EMBO journal.
[16] H. Atkins,et al. Characterization of Transgenic Mice with Targeted Disruption of the Catalytic Domain of the Double-stranded RNA-dependent Protein Kinase, PKR* , 1999, The Journal of Biological Chemistry.
[17] D. Choubey,et al. Differential induction of the 200-family proteins in Daudi Burkitt's lymphoma cells by interferon-alpha. , 2000, Journal of biological regulators and homeostatic agents.
[18] M. Barbacid,et al. Rac-1 dependent stimulation of the JNK/SAPK signaling pathway by Vav. , 1996, Oncogene.
[19] G. Sen,et al. Viruses and interferons. , 2001, Annual review of microbiology.
[20] J. Darnell,et al. ISGF3, the transcriptional activator induced by interferon alpha, consists of multiple interacting polypeptide chains. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[21] A. Kimchi. Cytokine triggered molecular pathways that control cell cycle arrest , 1992, Journal of cellular biochemistry.
[22] V. Rivera,et al. Regulation of chemokine receptor CCR5 and production of RANTES and MIP-1α by interferon-β , 2001, Journal of Neuroimmunology.
[23] M J Clemens,et al. The double-stranded RNA-dependent protein kinase PKR: structure and function. , 1997, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[24] S. Akira,et al. Toll-like receptors: critical proteins linking innate and acquired immunity , 2001, Nature Immunology.
[25] K. Schuebel,et al. Phosphotyrosine-dependent activation of Rac-1 GDP/GTP exchange by the vav proto-oncogene product , 1997, Nature.
[26] M. Esteban,et al. Induction of apoptosis by the dsRNA-dependent protein kinase (PKR): Mechanism of action , 2000, Apoptosis.
[27] L. Platanias,et al. Activation of the p 38 Mitogen-activated Protein Kinase by Type I Interferons , 1999 .
[28] L. Platanias,et al. A Region of the β Subunit of the Interferon α Receptor Different from Box 1 Interacts with Jak1 and Is Sufficient to Activate the Jak-Stat Pathway and Induce an Antiviral State* , 1997, The Journal of Biological Chemistry.
[29] O. Haller,et al. Enhanced virus resistance of transgenic mice expressing the human MxA protein , 1995, Journal of virology.
[30] G. Stark,et al. Characterization of β-R1, a Gene That Is Selectively Induced by Interferon β (IFN-β) Compared with IFN-α* , 1996, The Journal of Biological Chemistry.
[31] C. Heusser,et al. Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells , 1993, The Journal of experimental medicine.
[32] J. Gutterman,et al. Retardation of cell proliferation after expression of p202 accompanies an increase in p21(WAF1/CIP1). , 1999, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[33] I. Julkunen,et al. IFNs activate toll-like receptor gene expression in viral infections , 2001, Genes and Immunity.
[34] S. Landolfo,et al. The Ifi 200 genes: an emerging family of IFN-inducible genes. , 1998, Biochimie.
[35] B. Zhivotovsky,et al. Mechanisms of Interferon-alpha induced apoptosis in malignant cells , 2002, Oncogene.
[36] L. Platanias,et al. Interaction of the Transcriptional Activator Stat-2 with the Type I Interferon Receptor (*) , 1995, The Journal of Biological Chemistry.
[37] Y. Furukawa,et al. Transcriptional repression of the E2F-1 gene by interferon-α is mediated through induction of E2F-4/pRB and E2F-4/p130 complexes , 1999, Oncogene.
[38] C. Biron,et al. Natural killer cells in antiviral defense: function and regulation by innate cytokines. , 1999, Annual review of immunology.
[39] Robert H. Silverman,et al. Activation of p38 Mitogen-Activated Protein Kinase and c-Jun NH2-Terminal Kinase by Double-Stranded RNA and Encephalomyocarditis Virus: Involvement of RNase L, Protein Kinase R, and Alternative Pathways , 2000, Molecular and Cellular Biology.
[40] T. Taniguchi,et al. Antiviral response by natural killer cells through TRAIL gene induction by IFN–α/β , 2001, European journal of immunology.
[41] M. Dallman,et al. Impaired Antiviral Response and Alpha/Beta Interferon Induction in Mice Lacking Beta Interferon , 2000, Journal of Virology.
[42] S. Akira,et al. Small anti-viral compounds activate immune cells via the TLR7 MyD88–dependent signaling pathway , 2002, Nature Immunology.
[43] E. Fish,et al. The interferon-inducible Stat2:Stat1 heterodimer preferentially binds in vitro to a consensus element found in the promoters of a subset of interferon-stimulated genes. , 2001, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[44] R. Silverman,et al. Interferon action and apoptosis are defective in mice devoid of 2′,5′‐oligoadenylate‐dependent RNase L , 1997, The EMBO journal.
[45] P. Moore,et al. Interferon-κ, a Novel Type I Interferon Expressed in Human Keratinocytes* , 2001, The Journal of Biological Chemistry.
[46] B. Williams,et al. PKR; a sentinel kinase for cellular stress , 1999, Oncogene.
[47] M. White,et al. The IRS-signaling system: a network of docking proteins that mediate insulin and cytokine action. , 1998, Recent progress in hormone research.
[48] Amit Verma,et al. The p38 MAPK Pathway Mediates the Growth Inhibitory Effects of Interferon-α in BCR-ABL-expressing Cells* , 2001, The Journal of Biological Chemistry.
[49] B. Williams,et al. Functional classification of interferon‐stimulated genes identified using microarrays , 2001, Journal of leukocyte biology.
[50] R. Kumar,et al. Interferon-alpha signaling promotes nucleus-to-cytoplasmic redistribution of p95Vav, and formation of a multisubunit complex involving Vav, Ku80, and Tyk2. , 2000, Biochemical and biophysical research communications.
[51] J. Trapani,et al. The Human Interferon-inducible Protein, IFI 16, Is a Repressor of Transcription* , 1998, The Journal of Biological Chemistry.
[52] S. Manna,et al. IFN-α Suppresses Activation of Nuclear Transcription Factors NF-κB and Activator Protein 1 and Potentiates TNF-Induced Apoptosis1 , 2000, The Journal of Immunology.
[53] O. Haller,et al. Resistance to influenza virus and vesicular stomatitis virus conferred by expression of human MxA protein , 1990, Journal of virology.
[54] L. Platanias,et al. The CrkL adapter protein is required for type I interferon-dependent gene transcription and activation of the small G-protein Rap1. , 2002, Biochemical and biophysical research communications.
[55] D. Hober,et al. Inhibition of coxsackievirus B4 replication in stably transfected cells expressing human MxA protein. , 2001, Virology.
[56] P. Roberts,et al. Alpha/Beta Interferons Potentiate Virus-Induced Apoptosis through Activation of the FADD/Caspase-8 Death Signaling Pathway , 2000, Journal of Virology.
[57] N. Reich,et al. Tyrosine phosphorylation is required for activation of an alpha interferon-stimulated transcription factor. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[58] L. Platanias,et al. Interferon alpha induces rapid tyrosine phosphorylation of the alpha subunit of its receptor. , 1992, The Journal of biological chemistry.
[59] Abhrajyoti Ghosh,et al. A Specific Isozyme of 2′-5′ Oligoadenylate Synthetase Is a Dual Function Proapoptotic Protein of the Bcl-2 Family* , 2001, The Journal of Biological Chemistry.
[60] D. Grandér,et al. Molecular mechanisms underlying interferon-α-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins , 1999, Oncogene.
[61] C. Kahn,et al. The insulin signaling system. , 1994, The Journal of biological chemistry.
[62] P. Marrack,et al. Type I Interferons Keep Activated T Cells Alive , 1999, The Journal of experimental medicine.
[63] G. Stark,et al. How cells respond to interferons. , 1998, Annual review of biochemistry.
[64] J. Gutterman,et al. Inhibition of E2F-4/DP-1-stimulated transcription by p202 , 1997, Oncogene.
[65] D. Grandér,et al. Mechanisms of interferon-induced cell cycle arrest. , 2000, Frontiers in bioscience : a journal and virtual library.
[66] S. Landolfo,et al. The retinoblastoma protein is an essential mediator that links the interferon-inducible 204 gene to cell-cycle regulation , 2000, Oncogene.
[67] S. Gupta,et al. IFN-alpha activates Stat6 and leads to the formation of Stat2:Stat6 complexes in B cells. , 1999, Journal of immunology.
[68] T. Giese,et al. Toll‐like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL‐12 , 2001 .
[69] G. Kochs,et al. Self-assembly of Human MxA GTPase into Highly Ordered Dynamin-like Oligomers* , 2002, The Journal of Biological Chemistry.
[70] A. Verma,et al. Protein Kinase C-δ (PKC-δ) Is Activated by Type I Interferons and Mediates Phosphorylation of Stat1 on Serine 727* , 2002, The Journal of Biological Chemistry.
[71] I. Cremer,et al. A non‐classical ISRE/ISGF3 pathway mediates induction of RANTES gene transcription by type I IFNs , 2002, FEBS letters.
[72] O. Colamonici,et al. Cloning and Expression of a Long Form of the β Subunit of the Interferon αβ Receptor That Is Required for Signaling (*) , 1995, The Journal of Biological Chemistry.
[73] B. Hallberg,et al. Interferon-α Promotes Survival of Human Primary B-Lymphocytes via Phosphatidylinositol 3-Kinase , 2001 .
[74] L. Platanias,et al. Engagement of the CrkL adaptor in interferon α signalling in BCR–ABL‐expressing cells , 2001 .
[75] T. C. Wagner,et al. The Human Type I Interferon Receptor , 1996, The Journal of Biological Chemistry.
[76] L. Platanias,et al. Interferon alpha induces rapid tyrosine phosphorylation of the vav proto-oncogene product in hematopoietic cells. , 1994, The Journal of biological chemistry.
[77] M. White,et al. Interferon-α Engages the Insulin Receptor Substrate-1 to Associate with the Phosphatidylinositol 3′-Kinase (*) , 1995, The Journal of Biological Chemistry.
[78] A. Pizzey,et al. p130, p107, and pRb Are Differentially Regulated in Proliferating Cells and during Cell Cycle Arrest by α-Interferon* , 1998, The Journal of Biological Chemistry.
[79] A. Aguzzi,et al. Deficient signaling in mice devoid of double‐stranded RNA‐dependent protein kinase. , 1995, The EMBO journal.
[80] E. Raz,et al. Type I interferon is required to mount an adaptive response to immunostimulatory DNA , 2001, European journal of immunology.
[81] B. Williams,et al. Effect of deficiency of the double-stranded RNA-dependent protein kinase, PKR, on antiviral resistance in the presence or absence of ribonuclease L: HSV-1 replication is particularly sensitive to deficiency of the major IFN-mediated enzymes. , 2000, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[82] S. Vidal,et al. Functional diversity of Mx proteins: variations on a theme of host resistance to infection. , 2002, Genome research.
[83] V. ter meulen,et al. Cell type-specific MxA-mediated inhibition of measles virus transcription in human brain cells , 1994, Journal of virology.
[84] K. Pang,et al. Type I IFNs enhance the terminal differentiation of dendritic cells. , 1998, Journal of immunology.
[85] R. Silverman,et al. A dominant negative mutant of 2‐5A‐dependent RNase suppresses antiproliferative and antiviral effects of interferon. , 1993, The EMBO journal.
[86] Abhrajyoti Ghosh,et al. Cell growth regulatory and antiviral effects of the P69 isozyme of 2-5 (A) synthetase. , 2000, Virology.
[87] M. Karin,et al. JNK2 and IKKbeta are required for activating the innate response to viral infection. , 1999, Immunity.
[88] H. Kitayama,et al. Identification of Rap1 as a target for the Crk SH3 domain-binding guanine nucleotide-releasing factor C3G , 1995, Molecular and cellular biology.
[89] O. Colamonici,et al. Direct binding to and tyrosine phosphorylation of the alpha subunit of the type I interferon receptor by p135tyk2 tyrosine kinase , 1994, Molecular and cellular biology.
[90] A. Kimchi,et al. Close link between reduction of c-myc expression by interferon and G0/G1 arrest , 1985, Nature.
[91] S. Goodbourn,et al. Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures. , 2000, The Journal of general virology.
[92] D. J. Van Den Berg,et al. CrkL and CrkII participate in the generation of the growth inhibitory effects of interferons on primary hematopoietic progenitors. , 1999, Experimental hematology.
[93] B. Schumacher,et al. Vesicular stomatitis virus transcription inhibited by purified MxA protein. , 1995, Virology.
[94] D. Rebouillat,et al. The human 2',5'-oligoadenylate synthetase family: interferon-induced proteins with unique enzymatic properties. , 1999, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[95] C. Bréchot,et al. Inhibition of Hepatitis B Virus Replication by the Interferon-Inducible MxA Protein , 2001, Journal of Virology.
[96] O. Colamonici,et al. The type-I interferon receptor. The long and short of it. , 1996, Cytokine & growth factor reviews.
[97] M. Katze,et al. Constitutive expression of human double-stranded RNA-activated p68 kinase in murine cells mediates phosphorylation of eukaryotic initiation factor 2 and partial resistance to encephalomyocarditis virus growth , 1992, Journal of Virology.
[98] Pavel Kovarik,et al. Serine phosphorylation of STATs , 2000, Oncogene.
[99] B. Williams,et al. NF-κB Activation by Double-Stranded-RNA-Activated Protein Kinase (PKR) Is Mediated through NF-κB-Inducing Kinase and IκB Kinase , 2000, Molecular and Cellular Biology.
[100] A. Verma,et al. Activation of the p38 Mitogen-activated Protein Kinase Mediates the Suppressive Effects of Type I Interferons and Transforming Growth Factor-β on Normal Hematopoiesis* , 2002, The Journal of Biological Chemistry.
[101] V. Steunou,et al. p95vav associates with the type I interferon (IFN) receptor and contributes to the antiproliferative effect of IFN-α in megakaryocytic cell lines , 2000, Oncogene.
[102] P. Lengyel,et al. Binding of an Interferon-inducible Protein (p202) to the Retinoblastoma Protein (*) , 1995, The Journal of Biological Chemistry.
[103] A. Gamero,et al. Vanadate Facilitates Interferon α-mediated Apoptosis That Is Dependent on the Jak/Stat Pathway* , 2001, The Journal of Biological Chemistry.
[104] P. Cresswell,et al. Viperin (cig5), an IFN-inducible antiviral protein directly induced by human cytomegalovirus , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[105] L. Platanias,et al. The Type I Interferon Receptor Mediates Tyrosine Phosphorylation of the CrkL Adaptor Protein* , 1997, The Journal of Biological Chemistry.
[106] A. Lukashin,et al. Comparison of gene expression patterns induced by treatment of human umbilical vein endothelial cells with IFN-alpha 2b vs. IFN-beta 1a: understanding the functional relationship between distinct type I interferons that act through a common receptor. , 2002, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[107] L. Platanias,et al. Activation of a CrkL-Stat5 Signaling Complex by Type I Interferons* , 1999, The Journal of Biological Chemistry.
[108] S. Harroch,et al. Differential tyrosine phosphorylation of the IFNAR chain of the type I interferon receptor and of an associated surface protein in response to IFN‐alpha and IFN‐beta. , 1994, The EMBO journal.
[109] G. Kochs,et al. Human MxA protein inhibits tick-borne Thogoto virus but not Dhori virus , 1995, Journal of virology.
[110] J. Darnell,et al. Interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor. , 1992, Science.
[111] B. Williams,et al. Interferon action in triply deficient mice reveals the existence of alternative antiviral pathways. , 1999, Virology.
[112] F. Chisari,et al. Noncytolytic control of viral infections by the innate and adaptive immune response. , 2001, Annual review of immunology.
[113] M. White,et al. Activation of the phosphatidylinositol 3-kinase serine kinase by IFN-alpha. , 1997, Journal of immunology.
[114] L. Platanias,et al. Differential Use of the βL Subunit of the Type I Interferon (IFN) Receptor Determines Signaling Specificity for IFNα2 and IFNβ* , 1998, The Journal of Biological Chemistry.
[115] F. Sallusto,et al. Antigen decoding by T lymphocytes: from synapses to fate determination , 2001, Nature Immunology.
[116] A. Klöti,et al. Human MxA Protein Confers Resistance to Semliki Forest Virus and Inhibits the Amplification of a Semliki Forest Virus-Based Replicon in the Absence of Viral Structural Proteins , 1998, Journal of Virology.
[117] Y. Furukawa,et al. Modulation of E2F Activity Is Linked to Interferon-induced Growth Suppression of Hematopoietic Cells* , 1997, The Journal of Biological Chemistry.
[118] N. Sonenberg,et al. Regulatable expression of the interferon-induced double-stranded RNA dependent protein kinase PKR induces apoptosis and fas receptor expression. , 1999, Virology.
[119] G R Stark,et al. Formation of STAT1-STAT2 Heterodimers and Their Role in the Activation of IRF-1 Gene Transcription by Interferon- (*) , 1996, The Journal of Biological Chemistry.
[120] M. de Carli,et al. IL-4 and IFN (alpha and gamma) exert opposite regulatory effects on the development of cytolytic potential by Th1 or Th2 human T cell clones. , 1992, Journal of immunology.
[121] L. Platanias,et al. Association of the Interferon- dependent Tyrosine Kinase Tyk-2 with the Hematopoietic Cell Phosphatase (*) , 1995, The Journal of Biological Chemistry.
[122] O. Colamonici,et al. p135tyk2, an interferon-alpha-activated tyrosine kinase, is physically associated with an interferon-alpha receptor. , 1994, The Journal of biological chemistry.
[123] R. Silverman,et al. The role of 2′-5′ oligoadenylate-activated ribonuclease L in apoptosis , 1998, Cell Death and Differentiation.
[124] M. White,et al. The Type I Interferon Receptor Mediates Tyrosine Phosphorylation of Insulin Receptor Substrate 2 (*) , 1996, The Journal of Biological Chemistry.
[125] B. Williams,et al. The protein kinase PKR is required for p38 MAPK activation and the innate immune response to bacterial endotoxin , 2000, The EMBO journal.
[126] C. Biron. Interferons α and β as Immune Regulators—A New Look , 2001 .
[127] P. Roberts,et al. Essential role for the dsRNA-dependent protein kinase PKR in innate immunity to viral infection. , 2000, Immunity.
[128] R. Zinkernagel,et al. Antiviral defense in mice lacking both alpha/beta and gamma interferon receptors , 1995, Journal of virology.
[129] M. White,et al. The IRS-1 signaling system. , 1994, Trends in biochemical sciences.
[130] J. Darnell,et al. Contribution of STAT SH2 groups to specific interferon signaling by the Jak-STAT pathway , 1995, Science.